SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-027187
Filing Date
2016-11-03
Accepted
2016-11-03 09:01:59
Documents
94
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q Q3 2016 bmrn-10q_20160930.htm 10-Q 4285402
2 EX-31.1 bmrn-ex311_9.htm EX-31.1 16302
3 EX-31.2 bmrn-ex312_7.htm EX-31.2 16370
4 EX-32.1 bmrn-ex321_6.htm EX-32.1 5761
  Complete submission text file 0001564590-16-027187.txt   16560634

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bmrn-20160930.xml EX-101.INS 4913031
6 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20160930.xsd EX-101.SCH 63858
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmrn-20160930_cal.xml EX-101.CAL 78732
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmrn-20160930_def.xml EX-101.DEF 263441
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20160930_lab.xml EX-101.LAB 509192
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20160930_pre.xml EX-101.PRE 439301
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 161970333
SIC: 2834 Pharmaceutical Preparations